Belgium has many of the ingredients needed to be a strong leader in healthcare innovation. But as the healthcare landscape evolves, how can we ensure that patients benefit from innovation while keeping the system sustainable?
In this wide-ranging conversation, Bart Vermeulen, the new Chair of pharma.be, sets out his vision for the future of Belgium’s pharmaceutical sector. He looks at why innovation and affordability should be seen as complementary, what Belgium can learn from other healthcare systems, and why collaboration between patients, policymakers, healthcare professionals, and industry is essential.
From prevention and patient engagement to AI, personalised medicine, and the future of life sciences, Bart shares his thoughts on how Belgium can build on its strengths—and why the time to act is now.
The vision, innovation, and impact of pharma.be
Read the full interview with Bart Vermeulen, the new Chair of pharma.be, to explore his vision and perspectives.
Contact us
Connect with PwC Belgium
